Follow-The-Filings

Security · featured owners

JAZZ Jazz Pharmaceuticals PLC

Health Care SHS USD Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 15.4%
  • $55M
  • 1 new 1 reduce

JAZZ (Jazz Pharmaceuticals PLC) is held in 3 featured 13F books as of 2026 Q2. Michael Krensavage - Krensavage Asset Management is the largest tracked holder by portfolio weight (15.4%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 15.4% (Michael Krensavage - Krensavage Asset Management) · not free-float ownership

  1. Michael Krensavage 15.4%
  2. Tweedy, Browne Co. reduce 1.1%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Michael Krensavage - Krensavage Asset Management 2026 Q2 15.4% Hold 167,816 $40M history
Tweedy, Browne Co. 2026 Q2 1.1% Reduce −0.1% 60,149 $14M history
Polen Capital Management 2026 Q2 <0.01% New <0.01% 1,858 $448K history

3 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 9 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01 Filing Doc
8-K 1.01,2.03,3.02,8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 5 rows shown

Filed Form Detail Links
4 Period Sep 10, 2026 Filing Doc
4 Period Sep 8, 2026 · 2 forms Filing Doc
4 Period Aug 31, 2026 · 11 forms Filing Doc
4 Period Aug 27, 2026 Filing Doc
4 Period Aug 5, 2026 · 10 forms Filing Doc

Updated 2 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $3.83B $4.07B $4.27B
Net income $414.83M $560.12M -$356.15M
Net margin * 10.8% 13.8% -8.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $3.44B $4.63B $4.17B
Total non-current assets * $7.96B $7.38B $7.49B
Total assets $11.39B $12.01B $11.66B
Total current liabilities $1.54B $1.04B $2.24B
Total equity $3.74B $4.09B $4.32B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.09B $1.4B $1.36B
Cash from investing -$0.163B -$0.508B -$1.51B
Cash from financing -$305.25M $20.52M -$873.38M
Net change in cash $0.625B $0.907B -$1.02B

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders